Modoboa before 2.13.0 contains a CRLF injection vulnerability that allows Resellers or users with domain add or change permission to inject rspamd DKIM selector map entries by supplying an unvalidated dkim_key_selector through the relay domain API. Attackers can embed a carriage return in the selector to override another tenant's domain selector, causing rspamd to sign its outgoing mail with a nonexistent selector and fail DKIM verification.

Project Subscriptions

Vendors Products
Modoboa Subscribe
Modoboa Subscribe
Advisories

No advisories yet.

Fixes

Solution

No solution given by the vendor.


Workaround

No workaround given by the vendor.

History

Thu, 19 Nov 2026 16:00:00 +0000

Type Values Removed Values Added
Description Modoboa before 2.13.0 contains a CRLF injection vulnerability that allows Resellers or users with domain add or change permission to inject rspamd DKIM selector map entries by supplying an unvalidated dkim_key_selector through the relay domain API. Attackers can embed a carriage return in the selector to override another tenant's domain selector, causing rspamd to sign its outgoing mail with a nonexistent selector and fail DKIM verification.
Title Modoboa before 2.13.0 CRLF Injection via Relay Domain dkim_key_selector
First Time appeared Modoboa
Modoboa modoboa
Weaknesses CWE-93
CPEs cpe:2.3:a:modoboa:modoboa:*:*:*:*:*:*:*:*
Vendors & Products Modoboa
Modoboa modoboa
References
Metrics cvssV3_1

{'score': 2.7, 'vector': 'CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:L/A:N'}

cvssV4_0

{'score': 5.1, 'vector': 'CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N'}


Projects

Sign in to view the affected projects.

cve-icon MITRE

Status: PUBLISHED

Assigner: VulnCheck

Published:

Updated: 2026-11-19T15:52:19.315Z

Reserved: 2026-11-19T15:40:56.317Z

Link: CVE-2026-133236

cve-icon Vulnrichment

No data.

cve-icon NVD

Status : Received

Published: 2026-11-19T16:21:26.430

Modified: 2026-11-19T16:21:26.430

Link: CVE-2026-133236

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses